Key facts
- This page summarizes Daniel Stuart Farb's Form 3 filing for PharmaCyte Biotech, Inc. (PMCB).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Aug 2022, 06:02.
Daniel Stuart Farb - 15 Aug 2022 Form 3 Insider Report for PharmaCyte Biotech, Inc. (PMCB)
- Reporting relationship
- Director
- Issuer ticker
- PMCB
- Reported as of
- 15 Aug 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 23 Aug 2022, 06:02:07 UTC
- Next SEC filing
- 30 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Daniel S. Farb
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Daniel Stuart Farb filed Form 3 for PharmaCyte Biotech, Inc. (PMCB) on 23 Aug 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PMCB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 714,570
- Date
- 15 Aug 2022
- Ownership
- Big Mill Pond Capital Management LLC
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PMCB
holding
Derivative
Stock Option (short put)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 15 Aug 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 795,000
- Exercise price
- $2.50
* marks a reported price that did not pass the local price check.